Bullish
BranchLab, an AI platform for pharmaceutical commercialization, has successfully raised $26 million in Series A funding, led by McKesson Ventures with...
Wells Fargo has lowered its price target for McKesson (MCK) to $812 from $925, while maintaining an Equalweight rating on the stock. This adjustment c...
Bullish
McKesson Corporation reported strong financial results for Q4 fiscal 2026, with adjusted EPS surpassing analyst estimates despite revenue falling slig...
Neutral
McKesson Corporation announced that its final fiscal quarter revenue rose 6% year-over-year to $96.3 billion, missing market expectations, but adjuste...
Bearish
McKesson Corporation reported fourth-quarter results that surpassed earnings expectations but fell short on revenue, leading to a 2% decline in shares...
This article from MSN discusses the upcoming earnings report for McKesson (MCK), scheduled for tomorrow. It aims to provide insights into what investo...
Neutral
McKesson (NYSE: MCK), a healthcare distributor, is set to report earnings on Thursday. Investors are anticipating 11.9% year-on-year revenue growth, a...
Bullish
Artemis Investment Management LLP significantly increased its stake in McKesson Corporation, purchasing an additional 7,000 shares in Q4, bringing the...
Bullish
Ashton Thomas Securities LLC recently reduced its stake in McKesson Corporation by 17.9%, selling 1,497 shares and now holding 6,856 shares valued at ...
Neutral
Representative Lizzie Fletcher (D-Texas) recently sold shares of McKesson Corporation (NYSE: MCK) and several other major companies including Apple, K...
Neutral
Wall Street Zen has upgraded McKesson (NYSE:MCK) from "hold" to "buy," contributing to a consensus "Moderate Buy" rating from 14 analysts with an aver...
Bullish
McKesson (MCK) has seen substantial share price growth over five years but has cooled recently. A Discounted Cash Flow analysis indicates the stock is...
Bullish
Google's 2026 Discover Core Update is significantly changing how investors receive news and insights about McKesson Corporation stock, shifting toward...
Bullish
Axecap Investments LLC reduced its stake in McKesson Corporation by 30.5% in the fourth quarter, selling 1,256 shares and retaining 2,858 shares value...
Bullish
Calamos Advisors LLC reduced its stake in McKesson Corporation (NYSE:MCK) by 3.9% in the fourth quarter, selling 1,237 shares to own a total of 30,545...
Bullish
McKesson has entered into a $1.25 billion agreement with Apollo Funds, granting Apollo an approximately 13 percent ownership interest in its medical-s...
McKesson (MCK) has shown robust financial results with strong sales growth, faster earnings expansion, and ongoing share buybacks, driven by its signi...
Neutral
McKesson Corporation has sold a minority stake in its Medical-Surgical Solutions (MMS) business to Apollo Funds for $1.25 billion, valuing the unit at...
Neutral
McKesson Corporation, a dominant pharmaceutical distributor, plays a critical role in the U.S. healthcare supply chain. Its business model, strong mar...
Bullish
McKesson's wound care solutions for B2B and homecare are gaining traction due to rising chronic disease rates and an aging population. The company's s...